Studien

Studien in Durchführung:

SUNRISE-2

Post-Market Clinical Follow-Up Study to Confirm Clinical Performance and Safety of the Codman Enterprise® 2 Vascular Reconstruction Device in the Endovascular Treatment of Intracranial Aneurysms (SUNRISE-2)

clinicaltrials.gov/ct2/show/NCT02415010

MonDAFIS

Impact of standardised MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke (MonDAFIS)

Ziel: Mehrtägiges EKG Monitoring bei akuten Schlaganfallpatienten zum Nachweis von Vorhofflimmern

clinicaltrials.gov/ct2/show/NCT02204267

RE-SPECT ESUS

Randomized, double-blind evaluation in secondary stroke prevention comparing the efficacy and safety of the thrombin inhibitor dabigatran etexilate 110 or 150 mg (twice daily) versus acetylsalicytic acid (100mg once daily) in patients with controlled clinical trial Embolic Stroke of Undetermined Source (RE-SPECT ESUS).

Ziel: Vergleich von ASS versus Dabigatran bei Patienten mit kryptogenem Schlaganfall

clinicaltrials.gov/ct2/show/NCT02239120?term=respect+esus&rank=1

Schlaganfallregister RASUNOA-Prime

(Register Akuter Schlaganfall unter neuen oralen Antikoagulanzien)

clinicaltrials.gov/ct2/show/NCT02533960?term=rasunoa+prime&rank=1

© Neurovaskuläres Netzwerk Nordelbe